Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $142,122 - $176,449
-650 Reduced 41.56%
914 $245,000
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $26,109 - $30,590
-123 Reduced 7.29%
1,564 $333,000
Q2 2021

Jul 15, 2021

SELL
$233.58 - $259.14 $4,671 - $5,182
-20 Reduced 1.17%
1,687 $411,000
Q4 2020

Jan 28, 2021

SELL
$216.38 - $257.67 $6,491 - $7,730
-30 Reduced 1.73%
1,707 $392,000
Q2 2018

Jul 11, 2018

BUY
$166.05 - $186.51 $28,726 - $32,266
173 Added 11.06%
1,737 $321,000
Q3 2017

Oct 17, 2017

BUY
$167.29 - $191.0 $261,641 - $298,724
1,564
1,564 $292,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fenimore Asset Management Inc Portfolio

Follow Fenimore Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fenimore Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Fenimore Asset Management Inc with notifications on news.